Is it safe?
Can ADPT take a bad year?
Adaptive Biotechnologies Corporation holds $344M more cash than debt, and is burning $6.0M a quarter, about 14.3 years of cover.
$344M
Net cash
- Net debt / EBITDA
- net cash
Net debt / EBITDA · no net borrowings to measure against earnings
- Altman Z-score
- 3.70
Altman Z-score · safe zone, above 3
- Cash runway
- 5+ years
Cash runway · burning $6.0M a quarter at the current rate
Details›
- Total debtQ2 2026
- $0
- Cash and short-term investments
- $344M
- Net cash
- $344M
- EBITDA, trailing twelve months
- −$26M
- Operating profit, trailing twelve months
- −$37M
- Debt / equity
- 0.00×
- Annualised volatilitytwo years of daily moves
- 76%
- Worst drawdown on file
- −97%
- Below its 52-week high
- −0.29%
Balance sheet from SEC filings; drawdown and volatility from end-of-day closes; Altman Z from the filed statements.
Diagnostics & Research
Ranks #6 of 29 by Smart Score